Consistent with a previous report [9], 26 (76.5 %) tumor biopsies collected at disease progression after EGFR TKIs treatment showed high level ERK phosphorylation on immunohistochemistry (Fig. 1a). This evidence concerns the gene EGFR and neoplasm.